Get started
Author

Deborah A. Lew‐Kaya

Tazarotene gel, a new retinoid, for topical therapy of psoriasis: Vehicle-controlled study of safety, efficacy, and duration of therapeutic effect
1997 · Gerald D. Weinstein, Gerald G. Krueger, et al. · Journal of the American Academy of Dermatology · 182
Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks
2003 · Gerald D. Weinstein, John Y.M. Koo, et al. · Journal of the American Academy of Dermatology · 135
Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis
1998 · Mark G. Lebwohl, Debra L. Breneman, et al. · Journal of the American Academy of Dermatology · 131
Response of psoriasis to a new topical retinoid, AGN 190168
1994 · Teresa Esgleyes-Ribot, Roshantha A. Chandraratna, et al. · Journal of the American Academy of Dermatology · 128
Tazarotene Cream for the Treatment of Facial Photodamage
2001 · Sewon Kang, James J. Leyden, et al. · Archives of Dermatology · 113
Tazarotene plus UVB phototherapy in the treatment of psoriasis
2000 · John Y.M. Koo, Nicholas J. Lowe, et al. · Journal of the American Academy of Dermatology · 102
Efficacy of 0.1% Tazarotene Cream for the Treatment of Photodamage
2002 · Tania J. Phillips, Alice B. Gottlieb, et al. · Archives of Dermatology · 96
Tazarotene gel is safe and effective in the treatment of acne vulgaris: a multicenter, double-blind, vehicle-controlled study.
1999 · A R Shalita, D K Chalker, et al. · PubMed · 76
The Safety and Efficacy of Tazarotene Gel, a Topical Acetylenic Retinoid, in the Treatment of Psoriasis
1998 · Gerald G. Krueger, Lynn A. Drake, et al. · Archives of Dermatology · 72
A multicenter, randomized, double-blind trial of tazarotene 0.1% cream in the treatment of photodamage
2005 · Sewon Kang, Gerald G. Krueger, et al. · Journal of the American Academy of Dermatology · 48
Pharmacokinetics of Tazarotene Cream 0.1% After a Single Dose and After Repeat Topical Applications at Clinical or Exaggerated Application Rates in Patients with Acne Vulgaris or Photodamaged Skin
2003 · Zhiling Yu, John Sefton, et al. · Clinical Pharmacokinetics · 13
Once‐Daily Naftifine Cream 1% in the Treatment of Tinea Cruris and Tinea Corporis
1990 · Robert E. Jordon, Ronald P. Rapini, et al. · International Journal of Dermatology · 12
Evaluating psoriasis severity: limitations of the PASI and advantages of the overall lesional assessment
2004 · Deborah Lew-Kaya, John Lue, et al. · Journal of the American Academy of Dermatology · 6
PDF
Development of Rar Subtype Selective Retinoids for Dermatological Diseases
1995 · Roshantha A.S. Chandraratna, Elizabeth Henry, et al. · European Journal of Medicinal Chemistry · 4
Photographic documentation of the efficacy of oral tazarotene in nodulocystic acne
2004 · James J. Leyden, Deborah Lew-Kaya, et al. · Journal of the American Academy of Dermatology · 3
Oral tazarotene reduces comedones
2004 · Jerry K.L. Tan, Deborah Lew-Kaya, et al. · Journal of the American Academy of Dermatology · 3
AGN 190168, an investigational retinoid gel for the treatment of plaque psoriasis
1993 · J. Sefton, D. Lew-Kaya, et al. · Journal of Dermatological Science · 2
A long-term, open-label study of the safety and efficacy of oral tazarotene in moderate to very severe plaque psoriasis
2004 · Alan Menter, Deborah Lew-Kaya, et al. · Journal of the American Academy of Dermatology · 1
Safety of oral tazarotene in nodulocystic acne
2004 · Nicholas J. Lowe, Deborah Lew-Kaya, et al. · Journal of the American Academy of Dermatology · 1
FC043 Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis
1997 · J SEFTON, D LEWKAYA, et al. · Journal of the European Academy of Dermatology and Venereology · 1
Works count: 20
Citation count: 1,129
H-index: 12
I10-index: 12
Year
Topic
Type